|
1
|
Subramaniam GA, Nolan L, Huntley K, Corbin M, Crenshaw K, Mandell T, Linton J, Blackeney Q. National Institute on Drug Abuse: Dissemination of Scientific Knowledge to Improve Adolescent Health. Psychiatr Clin North Am 2023; 46:789-799. [PMID: 37879839 DOI: 10.1016/j.psc.2023.03.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2023]
Abstract
The wide and effective dissemination of research findings is crucial to the mission of the National Institute on Drug Abuse (NIDA). This article describes NIDA dissemination efforts and resources that are available to inform clinicians, teens, families, and educators about youth and substance use. Resources that are available include content addressing facts about youth drug use, trends in use, and stigma, in addition to substance use disorder (SUD) prevention and treatment. Information is provided about resources such as infographics, research-based practice guides, training, educational events, and online videos. How input is solicited to inform dissemination efforts is described and future directions for NIDA's dissemination efforts are outlined.
Collapse
Affiliation(s)
- Geetha A Subramaniam
- Center for the Clinical Trials Network, National Institute on Drug Abuse, 3WFN RM 09A54 MSC 6022, 301 North Stonestreet Avenue, Bethesda, MD 20892, USA.
| | - Laura Nolan
- JBS International, Inc., 5515 Security Lane, North Bethesda, MD 20852, USA
| | - Kristen Huntley
- Center for the Clinical Trials Network, National Institute on Drug Abuse, 3WFN RM 09A54 MSC 6022, 301 North Stonestreet Avenue, Bethesda, MD 20892, USA
| | - Michelle Corbin
- Center for the Clinical Trials Network, National Institute on Drug Abuse, 3WFN RM 09A54 MSC 6022, 301 North Stonestreet Avenue, Bethesda, MD 20892, USA
| | - Kenyatta Crenshaw
- The Bizzell Group LLC, 8201 Corporate Drive, 9th Floor, New Carrollton, MD 20785, USA
| | - Todd Mandell
- The Bizzell Group LLC, 8201 Corporate Drive, 9th Floor, New Carrollton, MD 20785, USA
| | - Janet Linton
- Center for the Clinical Trials Network, National Institute on Drug Abuse, 3WFN RM 09A54 MSC 6022, 301 North Stonestreet Avenue, Bethesda, MD 20892, USA; Center for Tobacco Products, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA
| | - Quandra Blackeney
- Center for the Clinical Trials Network, National Institute on Drug Abuse, 3WFN RM 09A54 MSC 6022, 301 North Stonestreet Avenue, Bethesda, MD 20892, USA
| |
Collapse
|
|
2
|
Subramaniam GA, Nolan L, Huntley K, Corbin M, Crenshaw K, Mandell T, Linton J, Blackeney Q. National Institute on Drug Abuse: Dissemination of Scientific Knowledge to Improve Adolescent Health. Child Adolesc Psychiatr Clin N Am 2023; 32:157-167. [PMID: 36410902 PMCID: PMC9942009 DOI: 10.1016/j.chc.2022.06.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The wide and effective dissemination of research findings is crucial to the mission of the National Institute on Drug Abuse (NIDA). This article describes NIDA dissemination efforts and resources that are available to inform clinicians, teens, families, and educators about youth and substance use. Resources that are available include content addressing facts about youth drug use, trends in use, and stigma, in addition to substance use disorder (SUD) prevention and treatment. Information is provided about resources such as infographics, research-based practice guides, training, educational events, and online videos. How input is solicited to inform dissemination efforts is described and future directions for NIDA's dissemination efforts are outlined.
Collapse
Affiliation(s)
- Geetha A Subramaniam
- Center for the Clinical Trials Network, National Institute on Drug Abuse, 3WFN RM 09A54 MSC 6022, 301 North Stonestreet Avenue, Bethesda, MD 20892, USA.
| | - Laura Nolan
- JBS International, Inc., 5515 Security Lane, North Bethesda, MD 20852, USA
| | - Kristen Huntley
- Center for the Clinical Trials Network, National Institute on Drug Abuse, 3WFN RM 09A54 MSC 6022, 301 North Stonestreet Avenue, Bethesda, MD 20892, USA
| | - Michelle Corbin
- Center for the Clinical Trials Network, National Institute on Drug Abuse, 3WFN RM 09A54 MSC 6022, 301 North Stonestreet Avenue, Bethesda, MD 20892, USA
| | - Kenyatta Crenshaw
- The Bizzell Group LLC, 8201 Corporate Drive, 9th Floor, New Carrollton, MD 20785, USA
| | - Todd Mandell
- The Bizzell Group LLC, 8201 Corporate Drive, 9th Floor, New Carrollton, MD 20785, USA
| | - Janet Linton
- Center for the Clinical Trials Network, National Institute on Drug Abuse, 3WFN RM 09A54 MSC 6022, 301 North Stonestreet Avenue, Bethesda, MD 20892, USA; Center for Tobacco Products, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA
| | - Quandra Blackeney
- Center for the Clinical Trials Network, National Institute on Drug Abuse, 3WFN RM 09A54 MSC 6022, 301 North Stonestreet Avenue, Bethesda, MD 20892, USA
| |
Collapse
|
|
3
|
Tai B, Dobbins R, Blackeney Q, Liu D, Moran L. The NIDA clinical trials network: evolving, expanding, and addressing the opioid epidemic. Addict Sci Clin Pract 2021; 16:28. [PMID: 33964973 PMCID: PMC8105960 DOI: 10.1186/s13722-021-00238-6] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2020] [Accepted: 04/24/2021] [Indexed: 11/12/2022] Open
Abstract
Over the past two decades, the National Drug Abuse Treatment Clinical Trials Network (CTN), a program of the National Institute on Drug Abuse (NIDA), has expanded from the initial six Nodes to 16 Nodes, as a nationwide consortium of research scientists and treatment providers working together to improve care for substance use in the nation’s communities. Encompassing both specialty care programs and general medical settings, the Network has become a unique resource for expertise on clinically focused research, bridging the gap between research and treatment delivery. Over 22 years, the CTN has completed 101 studies, resulting in 650 publications. In response to the opioid epidemic, a CTN task force generated a comprehensive list of research priorities in the areas of prevention, treatment, knowledge dissemination, and workforce training, to form the basis of the Network’s opioid portfolio. The Network’s opioid portfolio currently includes five main categories of studies: (1) large multi-site studies; (2) studies aimed at closing the treatment gap; (3) expansion of ongoing studies to improve service delivery and implementation; (4) studies to explore the use of substance use data in electronic health record systems; (5) training and dissemination projects to expand the research/health care provider workforce. With funding from the Helping to End Addiction Long-Term InitiativeSM (HEAL), the CTN established five new Nodes, which, along with the pre-existing Nodes, are distributed in every region of the nation and engage researchers and clinicians in areas that have been among the hardest hit by the opioid epidemic. Through this expanded network and its commitment to developing personalized, evidence-based treatments, the CTN is poised to address and provide solutions for the ongoing epidemic of opioid use and addiction.
Collapse
Affiliation(s)
- Betty Tai
- Center for the Clinical Trials Network, National Institute On Drug Abuse, National Institutes of Health, 3WFN Room 09A48 MSC 6022, 301 North Stonestreet Avenue, Bethesda, MD, 20892, USA.
| | - Ronald Dobbins
- Center for the Clinical Trials Network, National Institute On Drug Abuse, National Institutes of Health, 3WFN Room 09A48 MSC 6022, 301 North Stonestreet Avenue, Bethesda, MD, 20892, USA
| | - Quandra Blackeney
- Center for the Clinical Trials Network, National Institute On Drug Abuse, National Institutes of Health, 3WFN Room 09A48 MSC 6022, 301 North Stonestreet Avenue, Bethesda, MD, 20892, USA
| | - David Liu
- Center for the Clinical Trials Network, National Institute On Drug Abuse, National Institutes of Health, 3WFN Room 09A48 MSC 6022, 301 North Stonestreet Avenue, Bethesda, MD, 20892, USA
| | - Landhing Moran
- Center for the Clinical Trials Network, National Institute On Drug Abuse, National Institutes of Health, 3WFN Room 09A48 MSC 6022, 301 North Stonestreet Avenue, Bethesda, MD, 20892, USA
| |
Collapse
|